UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000015493
Receipt number R000017999
Scientific Title The new diagnosis method using nanobecon for colitis associated carcinoma
Date of disclosure of the study information 2014/11/01
Last modified on 2019/04/25 14:16:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The new diagnosis method using nanobecon for colitis associated carcinoma

Acronym

The new diagnosis method for colitis associated carcinoma

Scientific Title

The new diagnosis method using nanobecon for colitis associated carcinoma

Scientific Title:Acronym

The new diagnosis method for colitis associated carcinoma

Region

Japan


Condition

Condition

Ulcerative colitis
Colon carcinoma

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The efficacy of new diagnosis method using nanobecon for colitis associated carcinoma

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

The efficacy of new diagnosis method using nanobecon for colitis associated carcinoma

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Conventional historogical examaination

Interventions/Control_2

New immunohistochemisty using nanobecon

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with colon carcinoma or ulcerative colitis

Key exclusion criteria

1.Patients with severe ulcerative colitis
2.Patients concomitant with severe infection, heart failure, hepatic disorder, pulmonary disease, or CNS disease
3.Pregnant woman
4.Patients who did not agree with this study
5.Patients that physician determined inappropriate

Target sample size

34


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Nakase

Organization

Kyoto Univeristy Hospital

Division name

Gastroenterology and Hepatology

Zip code

606-8507

Address

54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto-city, Kyoto, Japan

TEL

075-751-4319

Email

hiropy_n@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Takuya
Middle name
Last name Yoshino

Organization

Kyoto Univeristy Hospital

Division name

Gastroenterology and Hepatology

Zip code

606-8507

Address

54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto-city, Kyoto, Japan

TEL

075-751-4319

Homepage URL


Email

tyocci@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Department of Gastroenterology and Hepatology, Kyoto Univeristy Hospital

Institute

Department

Personal name



Funding Source

Organization

ADEKA Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Department of pharmacy, Setsunan University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Institutional Review Board of Kyoto University Hospital

Address

54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto-city, Kyoto, Japan

Tel

0757534680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://www.sciencedirect.com/science/article/abs/pii/S093964111830883X?via%3Dihub

Number of participants that the trial has enrolled

0

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 10 Month 20 Day

Date of IRB

2015 Year 01 Month 19 Day

Anticipated trial start date

2014 Year 11 Month 15 Day

Last follow-up date

2018 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 10 Month 21 Day

Last modified on

2019 Year 04 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017999


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name